Profile data is unavailable for this security.
About the company
NeuroScientific Biopharmaceuticals Limited is an Australia-based company that is engaged in developing peptide-based pharmaceutical drugs that target a number of neurodegenerative conditions with high unmet medical demand. The Company’s product portfolio includes EmtinB, a therapeutic peptide initially targeting Alzheimer’s disease and glaucoma, as well as other Emtin peptides (EmtinAc, EmtinAn, and EmtinBn), which have demonstrated similar therapeutic potential as EmtinB. EmtinB is a peptide-based compound that binds to surface-based cell receptors from the LDLR family, activating intracellular signalling pathways that stimulate neuroprotection, neuroregeneration and modulate neuroinflammation. EmtinB is modelled on a specific active domain of the complex human protein called Metallothionein-IIA, which is produced as part of the human body’s innate immune response to cell injury.
- Revenue in AUD (TTM)3.94m
- Net income in AUD761.17k
- Incorporated2002
- Employees--
- LocationNeuroScientific Biopharmaceuticals LtdSuite 5, 85 Forrest St, CottesloeNEDLANDS 6011AustraliaAUS
- Phone+61 86382-1800
- Fax+61 86382-1801
- Websitehttps://neuroscientific.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hydration Pharmaceuticals Co Ltd | 15.17m | -12.24m | 3.45m | -- | -- | -- | -- | 0.2272 | -0.0628 | -0.0628 | 0.0777 | -0.002 | 1.18 | 1.61 | 6.60 | -- | -94.86 | -79.98 | -143.75 | -111.57 | 53.70 | 48.73 | -80.69 | -99.53 | 1.37 | -21.48 | 1.10 | -- | 10.34 | 19.27 | 23.61 | -- | -- | -- |
Bod Science Ltd | 3.32m | -7.95m | 4.26m | -- | -- | -- | -- | 1.28 | -0.0557 | -0.0557 | 0.0235 | -0.0046 | 0.7533 | 2.42 | 8.05 | -- | -180.40 | -94.62 | -465.66 | -145.77 | 69.23 | 47.08 | -239.47 | -129.48 | 0.8319 | -- | 3.71 | -- | -34.70 | 23.20 | -47.10 | -- | 8.23 | -- |
Cambium Bio Ltd | -28.22k | -366.01k | 5.36m | -- | -- | -- | -- | -- | -0.0012 | -0.0012 | -0.00009 | -0.0036 | -0.039 | -- | -- | -- | -50.58 | -49.44 | -- | -292.47 | -- | -- | -- | -118.34 | -- | -- | -- | -- | -- | -- | 60.86 | -- | -- | -- |
Invex Therapeutics Ltd | 837.95k | -6.01m | 5.86m | -- | -- | 1.11 | -- | 7.00 | -0.08 | -0.08 | 0.0112 | 0.0705 | 0.0521 | -- | 2.79 | -- | -37.38 | -- | -40.06 | -- | -- | -- | -717.76 | -- | -- | -- | 0.00 | -- | 379.22 | -- | -96.04 | -- | -- | -- |
Neuroscientific Biopharmaceuticals Ltd | 3.94m | 761.17k | 6.51m | -- | 8.33 | 1.71 | 7.83 | 1.65 | 0.0054 | 0.0054 | 0.0273 | 0.0264 | 1.02 | -- | 76.13 | -- | 19.64 | -55.72 | 23.29 | -60.89 | -- | -- | 19.34 | -301.54 | -- | 54.64 | 0.00 | -- | 7,292.97 | 179.97 | 89.76 | -- | -- | -- |
Island Pharmaceuticals Ltd | 10.28k | -2.37m | 6.71m | -- | -- | 8.46 | -- | 653.11 | -0.026 | -0.026 | 0.0001 | 0.007 | 0.0038 | -- | 0.0318 | -- | -88.77 | -- | -134.02 | -- | -- | -- | -23,100.68 | -- | -- | -- | 0.4433 | -- | -- | -- | -8.58 | -- | -- | -- |
Calmer Co International Ltd | 2.46m | -4.50m | 6.80m | -- | -- | -- | -- | 2.76 | -0.0091 | -0.0091 | 0.0042 | -0.0005 | 0.655 | 1.34 | 9.62 | -- | -119.81 | -139.15 | -231.33 | -198.55 | 36.03 | 30.26 | -182.94 | -388.81 | 0.482 | -9.36 | 1.22 | -- | -13.00 | 239.43 | 11.40 | -- | -- | -- |
Epsilon Healthcare Ltd | 7.21m | -5.93m | 7.21m | -- | -- | 0.7868 | -- | 0.9994 | -0.0198 | -0.0198 | 0.0241 | 0.0305 | 0.3839 | 17.94 | 2.73 | -- | -31.54 | -35.68 | -46.30 | -41.11 | 37.99 | 26.88 | -82.17 | -197.56 | 0.5237 | -9.28 | 0.2329 | -- | 29.36 | 30.99 | -43.77 | -- | 8.14 | -- |
Zelira Therapeutics Ltd | 1.62m | -36.43m | 7.60m | 8.00 | -- | -- | -- | 4.69 | -3.23 | -3.23 | 0.148 | -0.2063 | 0.0848 | 0.185 | 3.55 | -- | -193.14 | -27.71 | -243.04 | -28.81 | 82.28 | -- | -2,278.17 | -508.48 | 0.1488 | -22.80 | -- | -- | -80.95 | -0.3635 | 53.35 | -- | -- | -- |
Anatara Lifesciences Ltd | 0.00 | -1.75m | 7.84m | -- | -- | 5.43 | -- | -- | -0.014 | -0.014 | 0.00 | 0.0076 | 0.00 | -- | -- | -- | -103.15 | -59.64 | -115.72 | -66.52 | -- | -- | -- | -1,927.05 | -- | -- | 0.00 | -- | -- | -- | 20.10 | -- | -40.49 | -- |
Terragen Holdings Ltd | 2.60m | -2.53m | 8.86m | -- | -- | 1.30 | -- | 3.40 | -0.0099 | -0.0099 | 0.0101 | 0.0185 | 0.3364 | 0.5758 | 11.93 | -- | -32.71 | -43.86 | -39.59 | -50.11 | 96.61 | 87.96 | -97.24 | -173.81 | 5.79 | -347.50 | 0.0587 | -- | 13.67 | 31.22 | 40.19 | -- | -12.30 | -- |
Avecho Biotechnology Ltd | 473.55k | -3.44m | 9.51m | 29.00 | -- | 1.49 | -- | 20.08 | -0.0016 | -0.0016 | 0.0002 | 0.002 | 0.0888 | 2.07 | 0.5132 | -- | -64.45 | -47.08 | -75.73 | -55.25 | -9.25 | 78.67 | -725.70 | -156.43 | 8.19 | -- | 0.0267 | -- | -58.07 | -19.42 | -46.71 | -- | -- | -- |